ShadowBuys

USAspending · Contract award

A: Department of Health and Human Services contract award

IGF::CL::IGF; AGILENT TECHNOLOGIES INC:1109692 TN15004682 AGILENT 6224 LC/MS-TOF MASS SPECTROMETER IS THE WORK-HORSE INSTRUMENT IN THE BIOCHEMISTRY FACILITY AND ITS DEMAND IS KEEP INCREASING NOW. AS INCREASING THE USAGE, IT IS HIGHLY POSSIBLE THAT THE SYSTEM HAS MORE COMPLICATE PROBLEMS AND THESE PROBLEMS SHOULD BE REPAIRED AND MANAGED BY AN ENGINEER. THEREFORE, WE NEED TO RENEW THIS SERVICE CONTRACT FOR 01/01/2015 ~ 12/31/2015.

Follow A
First observed
Nov 10, 2026, 10:30 AM EST
Event / period date
Dec 3, 2014
Collected
Nov 10, 2026, 10:30 AM EST

Why this is connected

Exact legal-name match: AGILENT TECHNOLOGIES, INC. (https://www.sec.gov/Archives/edgar/data/1090872/).

Reported contract amount

$17,005.68

Source last modified: Jun 11, 2026

Award Amount is total obligations on this award, not a new incremental commitment or contract ceiling.

Source evidence

Read the source excerpt or record
{"internal_id":306984908,"Award ID":"HHSN268201500016U","Recipient Name":"AGILENT TECHNOLOGIES, INC.","Award Amount":17005.68,"Description":"IGF::CL::IGF; AGILENT TECHNOLOGIES INC:1109692 TN15004682 AGILENT 6224 LC/MS-TOF MASS SPECTROMETER IS THE WORK-HORSE INSTRUMENT IN THE BIOCHEMISTRY FACILITY AND ITS   DEMAND IS KEEP INCREASING NOW. AS INCREASING THE USAGE, IT IS HIGHLY POSSIBLE THAT THE SYSTEM HAS MORE COMPLICATE PROBLEMS AND THESE PROBLEMS SHOULD BE REPAIRED AND MANAGED BY AN ENGINEER. THEREFORE, WE NEED TO RENEW THIS SERVICE CONTRACT FOR 01/01/2015 ~ 12/31/2015.","Awarding Agency":"Department of Health and Human Services","Start Date":"2014-12-03","Last Modified Date":"2026-06-11 07:08:20","generated_internal_id":"CONT_AWD_HHSN268201500016U_7529_GS07F0564X_4732","awarding_agency_id":806,"agency_slug":"department-of-health-and-human-services"}

Congressional trading in A

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.